Please assess the completion status of the following clinical trial:

Trial Title: Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must undergo definitive local therapy with either breast conserving therapy or mastectomy~* Clinical Stage 0, I or II breast cancer based on examination and/or conventional imaging of mammogram with or without ultrasound. Tumors must be less than 5 cm in size and the patient clinically node negative~* Able to undergo breast MRI~Exclusion Criteria:~* Not pregnant or breastfeeding~* No prior breast MRI for the newly diagnosed carcinoma at the outside hospital~* No prior mantle radiation~* No locally advanced breast cancer~* No diffuse malignant appearing microcalcifications requiring mastectomy~* No known collagen vascular disease~* No previous ipsilateral radiation~* No participants who undergo surgery at an outside institution~* No prior history of breast carcinoma

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MRI (Type: ACTIVE_COMPARATOR): MRI
- No MRI (Type: NO_INTERVENTION): No MRI

Based on this trial design, predict the completion outcome and termination type (if applicable).